At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.
OEP, a well-rounded & multinational pharmaceutical company founded in 1982 and officially listed on the Taipei Exchange since 2003. OEP’s major business focuses on prescription medicines, nutricare and anti-aging. Furthermore, established subsidiary companies, OrientPharma and OP NanoPharma, to develop and manufacture new drugs to meet real human needs. The Company is committed to providing products and services that are valuable and unique. Through vertical integration, OEP provides clients with more comprehensive services, from clinical trial to marketing, and always striving to strategize in innovative fields, cultivating markets in the Asia Pacific and the US, and is working towards the goal of being the “Benchmark Enterprise in the Asia Pacific Region.”
Yes We Can Youth Clinics is recognised as the world-leading treatment centre for 13-25 year olds suffering from a wide array of mental health issues, addictions and related behavioural disorders. With a global reputation for excellence and the highest staff to client ratio in Europe (330+ staff vs 150 beds) over 5,000 young people have been through the Yes We Can Programme and gone on to rebuild their lives.
Otsuka Pharmaceutical is dedicated to the research & development of highly-innovative drugs and diagnostics. Leveraging our research culture of curiosity, determination and unconventional thinking, we strive for solutions that only Otsuka can deliver, to improve the health of people across the world.
Our R&D philosophy places emphasis on encouraging individual researchers to take the untraveled path, pursuing fresh ideas within a collaborative, accommodating environment. Supported by the global integration of our research and development institutes in Asia, the U.S. and Europe, the result has been epoch-making drugs.
We are Singapore’s leading specialty pharmaceutical and consumer healthcare group, leveraging on our diverse footprint in ASEAN countries. In part of our vision to provide a better quality of life to patients, we are constantly on the pulse of our industry’s innovation to meet patients’ needs.
Hyphens Pharma is a part of the Hyphens Group.
Listed on the Catalist board of Singapore Exchange (SGX)
DKSH is the leading Market Expansion Services provider with a focus on Asia. The Group helps companies to grow across the Business Units Healthcare, Consumer Goods, Performance Materials and Technology. The service portfolio covers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services.
Publicly listed on the SIX Swiss Exchange, the Group operates in 36 markets with 33,350 specialists, generating net sales of CHF 11.6 billion in 2019. With its Swiss heritage, DKSH has been deeply rooted in Asia Pacific since 1865. The DKSH Business Unit Healthcare distributes pharmaceuticals and healthcare products. With around 8,220 specialists, the Business Unit generated net sales of CHF 6.0 billion in 2019.
Routledge is the world’s leading academic publisher in the Humanities and Social Sciences. We publish thousands of books and journals each year, serving scholars, instructors, and professional communities worldwide. Our current publishing program encompasses groundbreaking textbooks and premier, peer-reviewed research in the Social Sciences, Humanities, Built Environment, Education and Behavioral Sciences. We have partnered with many of the most influential societies and academic bodies to publish their journals and book series. Readers can access tens of thousands of print and e-books from our extensive catalogue of titles.
One of the largest general interest trade book publishers in Southeast Asia, with a publishing history of over 50 years. Our subjects are diverse and encompass biographies, business, politics, travel, cuisine, culture, heritage, fiction, health and children’s titles.
Elsevier, a global leader in information and analytics, helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. Growing from our roots in publishing, we have supported the work of our research and health partners for more than 140 years. Combining content with technology, supported by operational efficiency, we turn information into actionable knowledge. Elsevier empowers knowledge which empowers those who use it.